4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

81.00p
   
  • Change Today:
    -2.75p
  • 52 Week High: 190.00
  • 52 Week Low: 68.83
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 68,200
  • Market Cap: £53.05m
  • Beta: 0.07

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
3.21% below the market average3.21% below the market average3.21% below the market average3.21% below the market average3.21% below the market average
48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
74.24% below the market average74.24% below the market average74.24% below the market average74.24% below the market average74.24% below the market average
54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average
Price Chg 3m
72.83% below the market average72.83% below the market average72.83% below the market average72.83% below the market average72.83% below the market average
54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
59.06% below the market average59.06% below the market average59.06% below the market average59.06% below the market average59.06% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average
Momentum 20
52.79% below the market average52.79% below the market average52.79% below the market average52.79% below the market average52.79% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
95.1% below the market average95.1% below the market average95.1% below the market average95.1% below the market average95.1% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
93.4% below the market average93.4% below the market average93.4% below the market average93.4% below the market average93.4% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
12.40% above the market average12.40% above the market average12.40% above the market average12.40% above the market average12.40% above the market average
25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average
Cash
23.22% above the market average23.22% above the market average23.22% above the market average23.22% above the market average23.22% above the market average
25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
71.68% above the market average71.68% above the market average71.68% above the market average71.68% above the market average71.68% above the market average
48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
20.15% above the market average20.15% above the market average20.15% above the market average20.15% above the market average20.15% above the market average
93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 81.00p
Change Today -2.75p
% Change -3.28 %
52 Week High 190.00
52 Week Low 68.83
Volume 68,200
Shares Issued 65.49m
Market Cap £53.05m
Beta 0.07

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
1.35% below the market average1.35% below the market average1.35% below the market average1.35% below the market average1.35% below the market average
10% below the sector average10% below the sector average10% below the sector average10% below the sector average10% below the sector average
Price Trend
87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average87.86% below the market average
77.05% below the sector average77.05% below the sector average77.05% below the sector average77.05% below the sector average77.05% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for 16-Aug-2019

Time Volume / Share Price
17:04 3,000 @ 81.00p
16:29 3,000 @ 82.44p
16:24 1,895 @ 79.50p
13:56 3,000 @ 79.00p
13:56 2,000 @ 79.00p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page